Ozelle is an innovative brand specializing in AI- and IoT-powered diagnostic systems that enhance healthcare and veterinary practices globally. Founded in 2014 in Silicon Valley, Ozelle has significantly advanced the field of diagnostic technology by transforming complex biological data into actionable clinical insights. Their diverse product offering includes cutting-edge hematology analyzers, such as the O-Cyte 1 and EHBT series, mini lab solutions, and veterinary diagnostic systems, all designed to streamline laboratory workflows and improve diagnostic accuracy.

With over 50,000 installations worldwide and daily generation of over 50 million cell images, Ozelle's AI models are continuously refined with real-world data, ensuring reliability and effectiveness across various clinical challenges. Their commitment to integrating AI with Complete Blood Morphology (CBM) allows clinicians to observe abnormal cells and make informed decisions swiftly. Ozelle's solutions empower healthcare providers by making intelligent diagnostics accessible and scalable, redefining the standard for clinical practice in both human and animal health.